Literature DB >> 2022733

Identification of the viral genes responsible for growth of strains of reovirus in cultured mouse heart cells.

Y Matoba1, B Sherry, B N Fields, T W Smith.   

Abstract

Viral growth in specific tissue is usually required in order to lead to pathology. Two reovirus isolates (type 1 Lang and type 3 Dearing) differ in their capacity to grow in cultured mouse heart cells. The mammalian reoviruses contain a genome of 10 double-stranded RNA gene segments. By the use of 37 reassortant viruses (consisting of viruses with different combinations of genes derived from the two parents), difference in capacity of different strains to grow in heart cells was mapped to three different genes, all of which encode viral core proteins: the M1 gene (P less than 0.000044); the L1 gene (P = 0.00094); and the L3 gene (P = 0.019). Using the same set of reassortant viruses, the L1 (P = 0.00015) and L3 (P = 0.0065) genes were involved in differences of the ability of viral strains to grow in mouse L cells (fibroblasts), but the M1 gene (P = 0.12) was not. These findings suggest that the M1 gene plays an important and specific role in determining the relative capacity of certain viral strains to grow in the heart. Thus, we have identified viral genes responsible for differing growth capacity in heart muscle cells in culture. These findings provide a novel system for studies of viral myocarditis at a molecular genetic level.

Entities:  

Mesh:

Year:  1991        PMID: 2022733      PMCID: PMC295247          DOI: 10.1172/JCI115177

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  REOVIRUS MYOCARDITIS IN MICE: AN ELECTRON MICROSCOPIC, IMMUNOFLUORESCENT, AND VIRUS ASSAY STUDY.

Authors:  S A HASSAN; E R RABIN; J L MELNICK
Journal:  Exp Mol Pathol       Date:  1965-02       Impact factor: 3.362

2.  Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue.

Authors:  R E Paque; C J Gauntt; T J Nealon; M D Trousdale
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

3.  Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3.

Authors:  R F Ramig; R K Cross; B N Fields
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

4.  Molecular basis of reovirus virulence: role of the S1 gene.

Authors:  H L Weiner; D Drayna; D R Averill; B N Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 5.  Cell proliferation during cardiac growth.

Authors:  R Zak
Journal:  Am J Cardiol       Date:  1973-02       Impact factor: 2.778

6.  Myocardial DNA synthesis in experimental cardiac hypertrophy.

Authors:  E Morkin; T P Ashford
Journal:  Am J Physiol       Date:  1968-12

7.  Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3.

Authors:  H L Weiner; K A Ault; B N Fields
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

8.  A genetic map of reovirus. 1. Correlation of genome RNAs between serotypes 1, 2, and 3.

Authors:  A H Sharpe; R F Ramig; T A Mustoe; B N Fields
Journal:  Virology       Date:  1978-01       Impact factor: 3.616

9.  Attenuation of Mengo virus through genetic engineering of the 5' noncoding poly(C) tract.

Authors:  G M Duke; J E Osorio; A C Palmenberg
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

10.  Derivation and characterization of an efficiently myocarditic reovirus variant.

Authors:  B Sherry; F J Schoen; E Wenske; B N Fields
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

View more
  20 in total

1.  A post-entry step in the mammalian orthoreovirus replication cycle is a determinant of cell tropism.

Authors:  Laura S Ooms; Takeshi Kobayashi; Terence S Dermody; James D Chappell
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

2.  Silencing and complementation of reovirus core protein mu2: functional correlations with mu2-microtubule association and differences between virus- and plasmid-derived mu2.

Authors:  John Carvalho; Michelle M Arnold; Max L Nibert
Journal:  Virology       Date:  2007-04-23       Impact factor: 3.616

3.  Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2.

Authors:  S E Rodgers; E S Barton; S M Oberhaus; B Pike; C A Gibson; K L Tyler; T S Dermody
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Identification and characterization of a double-stranded RNA- reovirus temperature-sensitive mutant defective in minor core protein mu2.

Authors:  K M Coombs
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  Core protein mu2 is a second determinant of nucleoside triphosphatase activities by reovirus cores.

Authors:  S Noble; M L Nibert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  The M1 gene is associated with differences in the temperature optimum of the transcriptase activity in reovirus core particles.

Authors:  P Yin; M Cheang; K M Coombs
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

7.  Identification of functional domains in reovirus replication proteins muNS and mu2.

Authors:  Takeshi Kobayashi; Laura S Ooms; James D Chappell; Terence S Dermody
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  Multiple viral core proteins are determinants of reovirus-induced acute myocarditis.

Authors:  B Sherry; M A Blum
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Association of the reovirus S1 gene with serotype 3-induced biliary atresia in mice.

Authors:  G A Wilson; L A Morrison; B N Fields
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  The reovirus M1 gene determines the relative capacity of growth of reovirus in cultured bovine aortic endothelial cells.

Authors:  Y Matoba; W S Colucci; B N Fields; T W Smith
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.